Similar Search Results

Consequences of the TRIPS-Agreement for the provision of pharmaceuticals in developing countries

Oppermann, Julia - 2008

Arzneimittel zur Behandlung dieser Krankheit. Zum anderen wurde auch der Mangel wirksamer Medikamente gegen vernachlässigte … Immatrialgüterrechte wesentliche Vorraussetzung für die konstante Entwicklung innovativer Arzneimittel seien. Kritiker des TRIPS … Arzneimittel gegen vernachlässigte Krankheiten bis zum 30.06.2008 überprüft. Unter Berücksichtigung des kurzfristigen …

Persistent link: https://www.econbiz.de/10009475357

Incentive Compatibility and Efficiency in the Contractual Insurer-Provider Relationship - Economic Theory and Practical Implications: The Case of North Carolina

Schmid, Andreas - 2007

eignet. Ein Exkurs zum amerikanischen Gesundheitswesen vermittelt dem Leser den n?tigen Hintergrund. Eine kritische …

Persistent link: https://www.econbiz.de/10009485586

Development and Gender Inequality ; Development and Gender Inequality

Lamanna, Francesca - 2013

Persistent link: https://www.econbiz.de/10010353250

HEALTH TOURISM - EVOLUTIONS AND PERSPECTIVES

GABRIELA, SLUSARIUC - 2020

This study presents the evolution of health tourism from antiquity to the present, and tries to highlight a conceptual analysis of health tourism, given its complexity of influence on the physical and mental level, from conception to the end of life, including all the aspect of life, physically...

Persistent link: https://www.econbiz.de/10015336008

MEDICAL TOURISM – A BUSINESS OR A NECESSITY?

PATRICHI, Ioana Cristiana; DODU, Silvia Patricia - 2014

Over the past few decades medical tourism has developed a strong international presence. Increasingly more people are turning to this type of tourism and there are already different specialized tourism companies that offer packages according to the needs of patients/tourists. In this context,...

Persistent link: https://www.econbiz.de/10015336887

Modelling variation of lower leg length growth in early life

Fong, DYT; Wong, SWS; Karlberg, JPE - 2001

We consider the estimation of sources of variation for panel data with repeated measurements. With no repeated measurements and known measurement error, models for variation decomposition have been proposed when there are one or more types of measurements. Estimation was performed using the EM...

Persistent link: https://www.econbiz.de/10009471512

The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide

Guerra, Carlos A.; Gikandi, Priscilla W.; Tatem, Andrew J. - 2008

Background: The efficient allocation of financial resources for malaria control using appropriate combinations of interventions requires accurate information on the geographic distribution of malaria risk. An evidence-based description of the global range of Plasmodium falciparum malaria and its...

Persistent link: https://www.econbiz.de/10009441519

Auswirkungen von Medikamentengenehmigungen auf die Bewertung von Biotech- und Pharmaunternehmen: Eine Ereignisstudie. Eine empirische Untersuchung

Sturm, Andreas - 2006

Die Arbeit untersucht den Einfluss der Genehmigung von Medikamenten durch die amerikanische Zulassungsbehörde FDA (Food and Drug Administration) auf den Aktienkurs der Antrag stellenden Aktiengesellschaft. Dabei werden Genehmigungen von wichtigen pharmazeutischen und biopharmazeutischen...

Persistent link: https://www.econbiz.de/10009450191

Consumer construction of the agricultural biotechnology industry's legitimacy: An empirical test of values congruency as institutional and actional legitimacy formation

Mosley, Raul A - 2006

institutional legitimacy) and to market drug-producing crops called Plant Made Pharmaceuticals (an instance of actional legitimacy …. Consumers were more slightly more likely to acknowledge the industry's right to market Plant Made Pharmaceuticals (r = .257 … as a big business entity and to market Plant Made Pharmaceuticals. …

Persistent link: https://www.econbiz.de/10009430368

Change agents and the evolution of the United States pharmaceutical industry, 1920--1960

Lee, Jeho - 1996

This dissertation examines the evolution of the market and the firms in the context of an emerging innovative race in the U.S. pharmaceutical industry. The history shows the existence of two distinct industry regimes. Before 1940, the industry can best be characterized as a competitive regime in...

Persistent link: https://www.econbiz.de/10009439017